Raleigh, North Carolina, United States | Fund Name | Location |
| Aeris Capital | Pfaffikon, Switzerland, Zurich |
| Alteon Websystems | California, San Jose, United States |
| Czar Capital | England, London, United Kingdom |
| Guangzhou Dangui Touzi Youxian Gongsi | China, Guangdong, Guangzhou |
| Hambrecht & Quist | California, San Francisco, United States |
| Journey Ventures | Israel, Tel Aviv, Tel Aviv District |
| Medidata Solutions | New York, New York, United States |
| Point West Ventures | Alpine, United States, Utah |
| PULLUP | Japan, Tokyo |
| Ronggong Touzi | China, Shanghai |
| S&G Investment | China, Shanghai |
| Sova VC | England, London, United Kingdom |
| Sungy Mobile | China, Guangdong, Guangzhou |
| Tako Ventures | California, San Francisco, United States |
| Tetragon Financial Group Limited | New York, New York, United States |
| The North Highland Company | Atlanta, Georgia, United States |
| Threadless | Chicago, Illinois, United States |
| TransLink | British Columbia, Burnaby, Canada |
| Yucaipa Corporate Initiatives Fund | California, Los Angeles, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lindy Biosciences | $1M | 18 Sep 2019 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lindy Biosciences | $1M | 18 Sep 2019 | Durham, North Carolina, United States |
